Tarveda has assembled a world-class team of scientific advisors that includes recognized experts in the fields of cancer metabolism, oncology, drug discovery, medicinal chemistry, nanomedicine, nanoparticle engineering, and drug delivery. These advisors work closely with Tarveda scientists to identify research directions as well as optimal combinations for Tarveda’s integrative medicines.
Neil H. Bander, M.D.
Bernard & Josephine Chaus Professor of Urologic Oncology, Weill Cornell Medical College, New York.
Philip Kantoff, MD
Chairman of Medicine, Memorial Sloan Kettering Cancer Center, Professor of Medicine, Weill Cornell Medical College, New York.
Gordon B. Mills, M.D., Ph.D.
Professor and Chair Systems Biology, Wiess Distinguished University Chair in Cancer Medicine. MD Anderson Cancer Center, Houston.
Jean-Charles Soria M.D., Ph.D.
Professor of Medicine and Medical Oncology at South-Paris University and Chair of the Drug Development Department, Gustave Roussy Cancer Center, Paris
Ralph Weissleder, MD, PhD
Thrall Professor of Radiology and Professor of Systems Biology, Harvard Medical School, Director, Center for Systems Biology, Massachusetts General Hospital, Boston
Omid Farokhzad MD
Associate Professor at Harvard Medical School and Director of Center for Nanomedicine at Brigham and Women's Hospital, Boston.
Robert Langer Sc.D.
David Koch Institute Professor, MIT, Cambridge.